Viraj Kulkarni
- Virology top 2%
- HIV Research and Treatment 19
- Immunology top 5%
- Immune Cell Function and Interaction 15
- Immunotherapy and Immune Responses 15
- T-cell and B-cell Immunology 6
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 5
- Otorhinolaryngology top 10%
- Biotechnology top 10%
-
- Herpesvirus Infections and Treatments 6
-
- vaccines and immunoinformatics approaches 4
- RNA Research and Splicing 4
- Co-authors
- Barbara K. FelberGeorge N. PavlakisDhananjaya SaranathMargherita RosatiAntonio ValentinCandido AliceaRashmi JalahCristina Bergamaschi
- Journals
- Vaccine (5 papers)The Journal of Immunology (5 papers)Human Vaccines & Immunotherapeutics (3 papers)
- Partner nations
- United StatesSpainIndia
In The Last Decade
Viraj Kulkarni
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Virology 404
- Immunology 670
- Infectious Diseases 163
- Otorhinolaryngology 32
- Biotechnology 61
Countries citing papers authored by Viraj Kulkarni
This map shows the geographic impact of Viraj Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viraj Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viraj Kulkarni more than expected).
Fields of papers citing papers by Viraj Kulkarni
This network shows the impact of papers produced by Viraj Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viraj Kulkarni. The network helps show where Viraj Kulkarni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Viraj Kulkarni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 6 | |
| 3 | 2021 | 33 | |
| 4 | 2021 | 24 | |
| 5 | 2021 | 1 | |
| 6 | 2016 | 29 | |
| 7 | 2015 | 7 | |
| 8 | 2015 | 7 | |
| 9 | 2014 | 20 | |
| 10 | 2013 | 10 | |
| 11 | 2013 | 40 | |
| 12 | DNA-MVA Prime-Boost Vaccine Eliciting T-Cell Specificities Associated with HIV-1 Control Is Highly Immunogenic in Mice and Breaks CTL Immunodominance | 2013 | 1 |
| 13 | 2012 | 54 | |
| 14 | 2010 | 47 | |
| 15 | 2010 | 20 | |
| 16 | 2009 | 43 | |
| 17 | 2009 | 91 | |
| 18 | 2007 | 35 | |
| 19 | 2006 | 49 | |
| 20 | 2003 | 119 |
About Viraj Kulkarni
Viraj Kulkarni is a scholar working on Virology, Immunology and Infectious Diseases, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (15 papers), Immunotherapy and Immune Responses (15 papers), Herpesvirus Infections and Treatments (6 papers), T-cell and B-cell Immunology (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), vaccines and immunoinformatics approaches (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Virology (404 citations), Immunology (670 citations) and Infectious Diseases (163 citations). Viraj Kulkarni has collaborated with scholars based in United States, Spain and India. Frequent co-authors include Barbara K. Felber, George N. Pavlakis, Dhananjaya Saranath, Margherita Rosati, Antonio Valentin, Candido Alicea, Rashmi Jalah, Cristina Bergamaschi, Vainav Patel and Gen‐Mu Zhang. Their work appears in journals such as Vaccine, The Journal of Immunology, Human Vaccines & Immunotherapeutics, Retrovirology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.